- About Us
- Advertise
- Contact Us
- Editorial Info
- Editorial Advisory Board
- Do Not Sell My Personal Information
- Privacy Policy
- Terms and Conditions
© 2024 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
Pharmaceutical Technology-11-02-2007
Pharmaceutical Technology
In the Spotlight November 2007
November 02, 2007
In the Spotlight
31
11
Editors' Picks of Pharmaceutical Science & Technology Innovations
Programming a Seamless Supply Chain
November 02, 2007
Special Report
31
11
Information technology is the glue that should unify a company while ironically, it enables further fragmentation. Experts talk about the successes and challenges for IT in helping a company function efficiently.
Investing in High-Potency Manufacturing
November 02, 2007
Articles
31
11
Market demand for cytotoxic drugs is leading CMOs to expand their API manufacturing and formulation services.
In the Field
November 02, 2007
In the Field
31
11
The US Food and Drug Administration launched a new program on Oct. 4 to increase the number and variety of generic drugs available to the public, beginning in fiscal year 2008. The Generic Initiative for Value and Efficiency (GIVE) will use existing resources to help the agency "modernize and streamline the generic drug approval process," according to FDA.
Mixed Message for Contract Manufacturers
November 02, 2007
Outsourcing
31
11
Candid comments from a Big Pharma executive highlight the complexity of contract manufacturing.
Improving a Pharmaceutical Water System based on a Risk Analysis Approach
November 02, 2007
Peer-Reviewed Research
31
11
In this study, fault tree analysis applied to a water pretreatment and purification installation exposed cause-and-effect complex interrelations in possible fault events.
Evaluating Mucilage from Aloe Barbadensis Miller as a Pharmaceutical Excipient for Sustained-Release Matrix Tablets
November 02, 2007
Peer-Reviewed Research
31
11
Natural gums and mucilage have been widely explored as pharmaceutical excipients. The goal of this study was to extract mucilage from the leaves of Aloe barbadensis Miller and to study its functionality as an excipient in pharmaceutical sustained-release tablet formulations.
Inside USP: Annual Scientific Meeting Recap
November 02, 2007
Inside USP
31
11
Representatives from 17 nations sit down to decide upon standards-setting initiatives.
Whom Can Patients Rely On?
November 02, 2007
This Time Around
31
11
As the mother of a 15-month-old, I was quite shaken last month to hear about over-the-counter cold medicines for children under age 2 being pulled off the shelves. Glued to the news, I wondered if the decongestant I had given my daughter when she was sick would have any negative impact on her long-term health.
Agent in Place: Statistically Unstable
November 02, 2007
Agent-In-Place
31
11
Thin are the lines that separate stability, statistics, and chaos.
The Continuing Story of Nanoparticles
November 02, 2007
Online Exclusive
31
11
A book illustrates the potential for nanoparticulate drug delivery, and how much about them remains to be understood.
FDA Amendments Act Raises Confidence and Questions
November 02, 2007
Washington Report
31
11
New FDA act reshapes drug development and marketing to restore public trust in pharmaceutical regulation.
Mixed-Flow Fans Meet Biosafety Level Laboratory Requirements
November 02, 2007
Peer-Reviewed Research
31
11
Mixed-flow impeller systems exhaust laboratory workstation fume hoods, prevent reentrainment into the facility and adjacent facilities, and help companies comply with appropriate pollution-control standards.
What Good is Winning a Prize if No One Cares?
November 02, 2007
From The Editor
31
11
Thanks to the media, Nobel Laureates are underrated, undervalued, and simply uncool.
The Excipient Information Package, A Win-Win Solution
November 02, 2007
Viewpoint
31
11
The EIP process addresses the problems encountered with numerous questionnaires when qualifying excipient manufacturers.